Baseline Circulating Tumor Cell Counts Significantly Enhance a Prognostic Score for Patients Participating in Phase I Oncology Trials (Q57693948)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 April 2011
edit
Language Label Description Also known as
English
Baseline Circulating Tumor Cell Counts Significantly Enhance a Prognostic Score for Patients Participating in Phase I Oncology Trials
scientific article published on 29 April 2011

    Statements

    Baseline circulating tumor cell counts significantly enhance a prognostic score for patients participating in phase I oncology trials (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit